SkinBiotix® technology generates positive data in first two elements of its human study

Manchester, UK - 7 November 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces positive data from the first two elements of its human study which focus on skin irritancy and moisturisation potential....

7th November, 2018 Read More

Full Year Results

Manchester, UK - 25 October 2018 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company") a life sciences company focused on skin health, has announced its full year results for the year to 30 June 2018....

25th October, 2018 Read More

CEO Presentation

CEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening https://www.sharesmagazine.co.uk/video/dr-catherine-oneill-ceo-skinbiotherapeutics-sbtx-2...

17th October, 2018 Read More

Human study commenced

Manchester, UK - 19 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the 'Company'), a life science company focused on skin health, confirms that it has commenced its human study being carried out on its SkinBiotix® technology....

19th September, 2018 Read More

CEO Presentation

CEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening...

14th September, 2018 Read More

Shares and AJ Bell Investor Evening

SkinBioTherapeutics will be attending and presenting at the Shares and AJ Bell evening event in Manchester on October 10 2018 at the Macdonald Manchester Hotel (nr Piccadilly Station). Shareholders and potential investors can register now for free at: https://www.sharesmagazine.co.uk/events...

14th September, 2018 Read More